semaglutide gastric stasis law firm in kentucky tirzepatide vs weight loss non-diabetic Tirzepatide vs Semaglutide: What's the Difference? Ozempic GLP-1 Lawsuit [2026]: Gastroparesis

Researchers estimated that semaglutide could cut the obesity prevalence in the United States by about 46% and prevent more than 1.5 million CVD events over 10 years when given to eligible patients with overweight or obesity

THERMO GLP-1TM** also activates Hormone Sensitive Lipase (HSL) in adipose fat tissue setting in motion the breakdown of diglycerides and triglycerides (formed fat) in white adipose fat tissue (WAT) and mobilizing (releasing) them into the bloodstream for BAT fuel use, which literally burns fat to generate HEAT as opposed to needing the body to work (exercise) the fat calories off

Probiotic Blend

Discover which FDA-approved weight loss medications, including Wegovy, Saxenda, and Zepbound, might be right for you

Fella Health honors veterans with exclusive $100 off our Weight Loss programs

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D2